TARAH BRACHER: Open Payments
NPI 1487266326 · NEWBURGH, IN. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$1,005 in 59 payments from 9 companies in 2025. Trend: 2023 $232 · 2024 $718 · 2025 $1,005
Food & beverage: $921Education: $84
| Company | Payments | Amount |
|---|---|---|
| Janssen Biotech, Inc. | 17 | $317 |
| ABBVIE INC. | 21 | $295 |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | 6 | $124 |
| Lilly USA, LLC | 6 | $100 |
| PFIZER INC. | 2 | $45 |
| Ardelyx, Inc. | 2 | $43 |
| Madrigal Pharmaceuticals | 2 | $39 |
| Phathom Pharmaceuticals, Inc. | 2 | $23 |
| Takeda Pharmaceuticals U.S.A., Inc. | 1 | $17 |
Products named: TREMFYA, RINVOQ, XIFAXAN, MAVYRET, OMVOH, XELJANZ, IBSRELA, REZDIFFRA.
Industry payments across IN — which companies pay providers there.
